Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia

Background: Phosphoinositide 3-kinase inhibitors (PI3Ki) are a new class of medications used to treat HR positive, HER2 negative, PIK3CA mutated advanced or metastatic breast cancer. Inhibition of PI3K, a key enzyme in the insulin signaling pathway, leads to disruption of glucose metabolism and freq...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Endocr Soc
Main Authors: Shey, Susan, Kim, Sarah, Kim, Julie, Murphy, Elizabeth J
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2021
Fag:
Diabetes Mellitus and Glucose Metabolism
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089671/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.803
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker